STOCK TITAN

Nuvalent to Participate in the BMO Virtual BioPharma Spotlight Series: Oncology Day

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Nuvalent, Inc. will participate in a fireside chat during the BMO Virtual BioPharma Spotlight Series: Oncology Day on November 8, 2023. The chat will feature James Porter, CEO, and Alexandra Balcom, CFO.
Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Nov. 1, 2023 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participate in a fireside chat during the BMO Virtual BioPharma Spotlight Series: Oncology Day on Wednesday, November 8, 2023, at 1:00 p.m. ET. 

A live webcast will be available in the Investors section of the company's website at www.nuvalent.com, and archived for 30 days following the presentation.

About Nuvalent
Nuvalent, Inc. (Nasdaq: NUVL) is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in chemistry and structure-based drug design, we develop innovative small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive non-small cell lung cancer, a program in HER2 Exon 20 insertion-positive cancers, and multiple discovery-stage research programs.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvalent-to-participate-in-the-bmo-virtual-biopharma-spotlight-series-oncology-day-301973608.html

SOURCE Nuvalent, Inc.

FAQ

When will Nuvalent, Inc. participate in the fireside chat?

Nuvalent, Inc. will participate in the fireside chat on Wednesday, November 8, 2023, at 1:00 p.m. ET.

Who will be participating in the fireside chat?

James Porter, Ph.D., the CEO of Nuvalent, Inc., and Alexandra Balcom, the CFO of the company, will be participating in the fireside chat.

Where can I watch the live webcast of the fireside chat?

The live webcast of the fireside chat will be available in the Investors section of Nuvalent, Inc.'s website at www.nuvalent.com.

Will the webcast be available after the presentation?

Yes, the webcast will be archived for 30 days following the presentation.

Nuvalent, Inc. Class A

NASDAQ:NUVL

NUVL Rankings

NUVL Latest News

NUVL Stock Data

4.56B
32.77M
3.7%
108.89%
10.08%
Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
United States of America
CAMBRIDGE

About NUVL

nuvalent is improving human health by developing breakthrough small molecule therapeutics that engage biological targets in new ways using cutting-edge chemical insights. by expanding the universe of targets that interact with small molecules, we are generating therapeutics with activities not previously possible, including modulation of ‘undruggable’ targets. our unique approach is leading to first-in-class and best-in-class small molecule therapeutics that will significantly impact patient’s lives.